Predictors of Recurrence after Catheter Ablation of Paroxysmal Atrial Fibrillation in Different Follow-Up Periods
<i>Background and objectives:</i> Pulmonary vein (PV) reconnection is a major reason for recurrence after catheter ablation of paroxysmal atrial fibrillation (PAF). However, the timing of the recurrence varies between patients, and recurrence >1 year after ablation is not uncommon. We...
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1010-660X/56/9/465 |
id |
doaj-5bf517558a77450da10b2be67f39af80 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Masako Baba Kentaro Yoshida Yoshihisa Naruse Ai Hattori Yoshiaki Yui Akira Kimata Yoko Ito Yasuaki Tsumagari Hidekazu Tsuneoka Yasutoshi Shinoda Tomohiko Harunari Yuichi Hanaki Hideyuki Hasebe Masako Misaki Daisuke Abe Akihiko Nogami Masaki Ieda Noriyuki Takeyasu |
spellingShingle |
Masako Baba Kentaro Yoshida Yoshihisa Naruse Ai Hattori Yoshiaki Yui Akira Kimata Yoko Ito Yasuaki Tsumagari Hidekazu Tsuneoka Yasutoshi Shinoda Tomohiko Harunari Yuichi Hanaki Hideyuki Hasebe Masako Misaki Daisuke Abe Akihiko Nogami Masaki Ieda Noriyuki Takeyasu Predictors of Recurrence after Catheter Ablation of Paroxysmal Atrial Fibrillation in Different Follow-Up Periods Medicina atrial fibrillation ablation recurrence natriuretic peptide remodeling |
author_facet |
Masako Baba Kentaro Yoshida Yoshihisa Naruse Ai Hattori Yoshiaki Yui Akira Kimata Yoko Ito Yasuaki Tsumagari Hidekazu Tsuneoka Yasutoshi Shinoda Tomohiko Harunari Yuichi Hanaki Hideyuki Hasebe Masako Misaki Daisuke Abe Akihiko Nogami Masaki Ieda Noriyuki Takeyasu |
author_sort |
Masako Baba |
title |
Predictors of Recurrence after Catheter Ablation of Paroxysmal Atrial Fibrillation in Different Follow-Up Periods |
title_short |
Predictors of Recurrence after Catheter Ablation of Paroxysmal Atrial Fibrillation in Different Follow-Up Periods |
title_full |
Predictors of Recurrence after Catheter Ablation of Paroxysmal Atrial Fibrillation in Different Follow-Up Periods |
title_fullStr |
Predictors of Recurrence after Catheter Ablation of Paroxysmal Atrial Fibrillation in Different Follow-Up Periods |
title_full_unstemmed |
Predictors of Recurrence after Catheter Ablation of Paroxysmal Atrial Fibrillation in Different Follow-Up Periods |
title_sort |
predictors of recurrence after catheter ablation of paroxysmal atrial fibrillation in different follow-up periods |
publisher |
MDPI AG |
series |
Medicina |
issn |
1010-660X |
publishDate |
2020-09-01 |
description |
<i>Background and objectives:</i> Pulmonary vein (PV) reconnection is a major reason for recurrence after catheter ablation of paroxysmal atrial fibrillation (PAF). However, the timing of the recurrence varies between patients, and recurrence >1 year after ablation is not uncommon. We sought to elucidate the characteristics of atrial fibrillation (AF) that recurred in different follow-up periods. <i>Materials and Methods:</i> Study subjects comprised 151 consecutive patients undergoing initial catheter ablation of PAF. Left atrial volume index (LAVi) and atrial/brain natriuretic peptide (ANP/BNP) levels were systematically measured annually over 3 years until AF recurred. <i>Results:</i> Study subjects were classified into four groups: non-recurrence group (<i>n</i> = 84), and short-term- (within 1 year) (<i>n</i> = 30), mid-term- (1–3 years) (<i>n</i> = 26), and long-term-recurrence group (>3 years) (<i>n</i> = 11). The short-term-recurrence group was characterized by a higher prevalence of diabetes mellitus (hazard ratio 2.639 (95% confidence interval, 1.174–5.932), <i>p</i> = 0.019 by the Cox method), frequent AF episodes (≥1/week) before ablation (4.038 (1.545–10.557), <i>p</i> = 0.004), and higher BNP level at baseline (per 10 pg/mL) (1.054 (1.029–1.081), <i>p</i> < 0.0001). The mid-term-recurrence group was associated with higher BNP level (1.163 (1.070–1.265), <i>p</i> = 0.0004), larger LAVi (mL/m<sup>2</sup>) (1.033 (1.007–1.060), <i>p</i> = 0.013), and longer AF cycle length at baseline (per 10 ms) (1.194 (1.058–1.348), <i>p</i> = 0.004). In the long-term-recurrence group, the ANP and BNP levels were low throughout follow-up, as with those in the non-recurrence group, and AF cycle length was shorter (0.694 (0.522–0.924), <i>p</i> = 0.012) than those in the other recurrence groups. <i>Conclusions:</i> Distinct characteristics of AF were found according to the time to first recurrence after PAF ablation. The presence of secondary factors beyond PV reconnections could be considered as mechanisms for the recurrence of PAF in each follow-up period. |
topic |
atrial fibrillation ablation recurrence natriuretic peptide remodeling |
url |
https://www.mdpi.com/1010-660X/56/9/465 |
work_keys_str_mv |
AT masakobaba predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods AT kentaroyoshida predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods AT yoshihisanaruse predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods AT aihattori predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods AT yoshiakiyui predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods AT akirakimata predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods AT yokoito predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods AT yasuakitsumagari predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods AT hidekazutsuneoka predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods AT yasutoshishinoda predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods AT tomohikoharunari predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods AT yuichihanaki predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods AT hideyukihasebe predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods AT masakomisaki predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods AT daisukeabe predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods AT akihikonogami predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods AT masakiieda predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods AT noriyukitakeyasu predictorsofrecurrenceaftercatheterablationofparoxysmalatrialfibrillationindifferentfollowupperiods |
_version_ |
1724612347861925888 |
spelling |
doaj-5bf517558a77450da10b2be67f39af802020-11-25T03:21:56ZengMDPI AGMedicina1010-660X2020-09-015646546510.3390/medicina56090465Predictors of Recurrence after Catheter Ablation of Paroxysmal Atrial Fibrillation in Different Follow-Up PeriodsMasako Baba0Kentaro Yoshida1Yoshihisa Naruse2Ai Hattori3Yoshiaki Yui4Akira Kimata5Yoko Ito6Yasuaki Tsumagari7Hidekazu Tsuneoka8Yasutoshi Shinoda9Tomohiko Harunari10Yuichi Hanaki11Hideyuki Hasebe12Masako Misaki13Daisuke Abe14Akihiko Nogami15Masaki Ieda16Noriyuki Takeyasu17Department of Cardiology, Ibaraki Prefectural Central Hospital, Kasama 309-1793, JapanDepartment of Cardiology, Ibaraki Prefectural Central Hospital, Kasama 309-1793, JapanDepartment of Cardiology, Ibaraki Prefectural Central Hospital, Kasama 309-1793, JapanDepartment of Cardiology, Ibaraki Prefectural Central Hospital, Kasama 309-1793, JapanDepartment of Cardiology, Ibaraki Prefectural Central Hospital, Kasama 309-1793, JapanDepartment of Cardiology, Ibaraki Prefectural Central Hospital, Kasama 309-1793, JapanDepartment of Cardiology, Ibaraki Prefectural Central Hospital, Kasama 309-1793, JapanDepartment of Cardiology, Ibaraki Prefectural Central Hospital, Kasama 309-1793, JapanDepartment of Cardiology, Ibaraki Prefectural Central Hospital, Kasama 309-1793, JapanDepartment of Cardiology, Ibaraki Prefectural Central Hospital, Kasama 309-1793, JapanDepartment of Cardiology, Ibaraki Prefectural Central Hospital, Kasama 309-1793, JapanDepartment of Cardiology, Ibaraki Prefectural Central Hospital, Kasama 309-1793, JapanDepartment of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, JapanDepartment of Cardiology, Ibaraki Prefectural Central Hospital, Kasama 309-1793, JapanDepartment of Cardiology, Ibaraki Prefectural Central Hospital, Kasama 309-1793, JapanDepartment of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, JapanDepartment of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, JapanDepartment of Cardiology, Ibaraki Prefectural Central Hospital, Kasama 309-1793, Japan<i>Background and objectives:</i> Pulmonary vein (PV) reconnection is a major reason for recurrence after catheter ablation of paroxysmal atrial fibrillation (PAF). However, the timing of the recurrence varies between patients, and recurrence >1 year after ablation is not uncommon. We sought to elucidate the characteristics of atrial fibrillation (AF) that recurred in different follow-up periods. <i>Materials and Methods:</i> Study subjects comprised 151 consecutive patients undergoing initial catheter ablation of PAF. Left atrial volume index (LAVi) and atrial/brain natriuretic peptide (ANP/BNP) levels were systematically measured annually over 3 years until AF recurred. <i>Results:</i> Study subjects were classified into four groups: non-recurrence group (<i>n</i> = 84), and short-term- (within 1 year) (<i>n</i> = 30), mid-term- (1–3 years) (<i>n</i> = 26), and long-term-recurrence group (>3 years) (<i>n</i> = 11). The short-term-recurrence group was characterized by a higher prevalence of diabetes mellitus (hazard ratio 2.639 (95% confidence interval, 1.174–5.932), <i>p</i> = 0.019 by the Cox method), frequent AF episodes (≥1/week) before ablation (4.038 (1.545–10.557), <i>p</i> = 0.004), and higher BNP level at baseline (per 10 pg/mL) (1.054 (1.029–1.081), <i>p</i> < 0.0001). The mid-term-recurrence group was associated with higher BNP level (1.163 (1.070–1.265), <i>p</i> = 0.0004), larger LAVi (mL/m<sup>2</sup>) (1.033 (1.007–1.060), <i>p</i> = 0.013), and longer AF cycle length at baseline (per 10 ms) (1.194 (1.058–1.348), <i>p</i> = 0.004). In the long-term-recurrence group, the ANP and BNP levels were low throughout follow-up, as with those in the non-recurrence group, and AF cycle length was shorter (0.694 (0.522–0.924), <i>p</i> = 0.012) than those in the other recurrence groups. <i>Conclusions:</i> Distinct characteristics of AF were found according to the time to first recurrence after PAF ablation. The presence of secondary factors beyond PV reconnections could be considered as mechanisms for the recurrence of PAF in each follow-up period.https://www.mdpi.com/1010-660X/56/9/465atrial fibrillationablationrecurrencenatriuretic peptideremodeling |